Company / EPS (Diluted)
AYTU BIOPHARMA, INC EPS (Diluted) History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$74.01
FY2023
5-year range
-$74.01 / -$3.01
FY2019-FY2023
Trend
-2026.7%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -2027% YoY in FY2023, a notable deviation from the 7-year average annual change of -875%.
Based on SEC 10-K filings.
-74.01 in FY2023.
Declined from $-3.01 to $-74.01 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, eps (diluted) decreased 2026.7% year-over-year.
- Peak eps (diluted) was recorded in FY2015.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -$74.01 | -2026.7% |
| FY2022 | -$3.48 | -15.6% |
| FY2021 | -$3.01 | +13.5% |
| FY2020 | -$3.48 | +92.8% |
| FY2018 | -$48.30 | +85.1% |
| FY2017 | -$323.70 | -3114.5% |
| FY2016 | -$10.07 | -1158.7% |
| FY2015 | -$0.80 | -7900.0% |
As of FY2023 · SEC Form 10-K · Last checked Jun 21, 2026